In addition, LINC00662 overexpression predicted advanced tumor stage (OR = 4.23, 95% CI 2.50-7.17, <i>p</i> < 0.001), larger tumor size (OR = 1.49, 95% CI 1.11-1.99, <i>p</i> = 0.008), earlier lymph node metastasis (OR = 2.40, 95% CI 1.25-4.59, <i>p</i> = 0.008), and earlier distant metastasis (OR = 4.78, 95% CI 2.57-8.88, <i>p</i> < 0.001). Here, LINC00662 is linked to neoplasm.